Search Results
Sep 04, 2025, 09:00 ET IndagoAI Launches Differentiated AI-Powered Platform for Custom Product and Services Development
including Microsoft, NCR/Bell Labs, McGraw Hill/S&P Global, LexisNexis, Reed Elsevier, and BMI Inc. Mairhofer, a startup and enterprise veteran, has served in leadership roles at Fortune 500 companies including Dell/EMC, S&P Global, McGraw
More news about: IndagoAI
Sep 03, 2025, 12:00 ET BMI Imaging Exhibits at NACM 2025 in Omaha, Showcasing Secure Court Records Digitization
administration. At NACM, BMI highlighted its proven capabilities of converting paper and microfilm into searchable digital records, precise indexing, and day-forward capture, supported by secure hosting options. As a CJIS-listed and SOC 2 Type II audited organization, BMI designs solutions that
More news about: BMI Imaging Systems, Inc.
Sep 03, 2025, 10:11 ET MyOme Expands Proactive Health Portfolio with Launch of Type 2 Diabetes Integrated Polygenic Risk Score (iPRS)™
genetics-informed risk assessment that integrates information from a whole-genome analysis with family history and commonly collected clinical risk factors (e.g., BMI, blood glucose, lipids). The T2D iPRS has been validated across multiple ancestries, reflecting MyOme's cross-ancestry PRS (caPRS) approach that improves
More news about: MyOme, Inc
Sep 02, 2025, 07:30 ET Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025
certified coaches and educational content provide the right support at the right time.Prediabetes: 10% reduction in body mass index (BMI)Dario helps members adopt healthy habits and reverse the prediabetes trend, using Dario devices and our motivating coaching program
More news about: DarioHealth Corp.
Aug 31, 2025, 03:00 ET Novo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
overweight or obesity and established CVD with no prior history of diabetes. People included in the trial were aged ≥45 years with a body mass index (BMI) of ≥27 kg/m2.8 The primary objective of the SELECT trial was to demonstrate the superiority of Wegovy® compared
More news about: NOVO NORDISK INC.
Aug 27, 2025, 19:45 ET Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study
NCT06680440), conducted in the U.S., of ASC30 oral once-daily tablet in participants with obesity (body mass index (BMI): 30-40 kg/m2). At steady state, ASC30 demonstrated drug exposures (area under the curve over 0-24 hours or AUC0-24h) of 3,560
More news about: Ascletis Pharma Inc.
Aug 27, 2025, 12:00 ET BMI Imaging's "The Digital Imaging Channel" Passes 500 Subscribers
secure hosting designed for government, education, and commercial teams modernizing their records. About BMIEstablished in 1958 as Bay Microfilm Incorporated, BMI Imaging Systems embarked on a mission to assist County Recorders with archiving land records on microfilm. By the 1960s,
More news about: BMI Imaging Systems, Inc.
Aug 26, 2025, 06:45 ET Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
was to demonstrate that orforglipron (6 mg, 12 mg, 36 mg) is superior to placebo in mean body weight change from baseline at 72 weeks in people with a BMI ≥27.0 kg/m² and type 2 diabetes who are on stable treatment with either diet/exercise alone or up to three oral antihyperglycemic medications. All participants
More news about: Eli Lilly and Company
Aug 21, 2025, 15:23 ET Veterans Disability Attorney Eric Gang Featured in Woman's World Discussing Military Diet and Veteran Health
expenses but also lost readiness, recruitment challenges, and national security concerns. In fact, nearly one-third of Army reserve recruits fail to meet BMI standards. "People don't use lawyers like me for easy cases," Gang says in the article. His clients are often veterans battling complex, chronic
More news about: Gang & Associates LLC
Aug 21, 2025, 13:54 ET GRAMMY, BRIT AND IVOR AWARD-WINNING PRODUCER AND SONGWRITER FRASER T. SMITH TO BE HONOURED WITH THE BMI PRESIDENT'S AWARD AT THE 2025 BMI LONDON AWARDS
Aug. 21, 2025 /PRNewswire/ -- BMI today announced that Fraser T. Smith will be presented with the BMI President's Award at the 2025 BMI London Awards held on 29 September at The Dorchester. The
More news about: Broadcast Music, Inc.
Aug 21, 2025, 08:56 ET Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law
injectable and topical medications; Unlike certain hormonal contraceptives, PHEXXI can be prescribed for and used by women with any body mass index (BMI); and PHEXXI was
More news about: Evofem Biosciences, Inc.
Aug 20, 2025, 17:00 ET New Peer-Reviewed Study in New England Journal of Medicine Catalyst Finds Twin Health's AI Precision Treatment Significantly Improves Outcomes in Patients with Type 2 Diabetes and Reduces Reliance on Costly Medications, Including GLP-1s
group. On average, patients were 58.5 years old, had been living with type 2 diabetes for about nine years, and presented with a mean body mass index (BMI) of 35.1 and an average A1C level of 7.2%. The primary endpoint was to see how many participants reached an A1C below 6.5% after 12 months without
More news about: Twin Health
Aug 20, 2025, 08:30 ET Atossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer
studies with tamoxifen demonstrate an inverse correlation between endoxifen blood concentration and hot flash severity score following adjustment for age, BMI, and menopausal status, suggesting it may deliver a better tolerance profile. Atossa's proprietary oral, enteric-coated formulation is designed
More news about: Atossa Therapeutics Inc
Aug 19, 2025, 10:32 ET Global Mammography Equipment Market Accelerates with Smart Imaging Innovations
expected to drive future growth and improve access to breast cancer screening worldwide.Market leaders include: BMI BIOMEDICAL INTERNATIONAL S.R.L.CANON INC.FUJIFILM HOLDINGS CORP.GE HEALTHCAREGENORAY CO. LTD.HOLOGIC INC.ITALRAYKONINKLIJKE
More news about: BCC Research LLC
Aug 19, 2025, 10:15 ET Care Resource Earns National Recognition as a Clinical Quality Leader for 2025
and data-driven care coordination.Preventive Health – for exceeding benchmarks in areas such as depression screening, tobacco cessation, and BMI screening."Being recognized with the 2025 Health Center Quality Leader Gold badge and multiple National Quality Leader designations is a
More news about: Care Resource
Aug 19, 2025, 07:08 ET Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
cohort = 30 mg x 2 weeks, 60 mg x 2 weeks, 90 mg x 2 weeks, 120 mg x 7 weeks. 3) All enrolled participants were required to have baseline BMI ≥30 kg/m2 or BMI≥27 kg/m2 with at least one weight-related comorbid condition. 4) Least squares mean. 5) Two-sided t-test using mixed model for
More news about: Viking Therapeutics, Inc.
Aug 18, 2025, 10:01 ET Epoxy Resin Market is expected to generate a revenue of USD 21.37 Billion by 2032, Globally, at 5.9% CAGR: Verified Market Research®
Global Carbon Fiber Prepreg Market Size By Fiber Type (Standard Modulus, Intermediate Modulus, High Modulus), By Resin System (Epoxy, BMI, Cyanate Ester), By End-User Industry (Aerospace, Automotive, Wind Energy), By Geography, And Forecast
More news about: Verified Market Research
Aug 14, 2025, 15:00 ET RIVANNA secures $800,000 Virginia Catalyst Grant alongside matching funds to advance AI-enabled ultrasound platform for neuraxial anesthesia
improving provider efficiency during epidural placements. These advantages will be especially impactful for challenging cases, such as in patients with high BMI or anatomical abnormalities. The Virginia Catalyst Award will specifically support the finalization and clinical validation of advanced product
More news about: RIVANNA
Aug 07, 2025, 11:25 ET Gerina hace equipo con el legendario Chico & The Gypsies para electrizar la nueva versión de "Arrepentido"
musical. Como compositora consumada, Gerina ya ha logrado un éxito notable, con puestos n.° 1 del ranking en su haber y un prestigioso Premio BMI a la mejor canción del año por el sencillo de Thalía. Sus habilidades como compositora han sido reconocidas a nivel mundial y ha trabajado con los mejores
More news about: Mission Records LLC
Aug 07, 2025, 10:30 ET Gerina s'associe au légendaire Chico & The Gypsies pour une nouvelle version électrisante de « Arrepentido »
musique. En tant qu'autrice-compositrice accomplie, Gerina a déjà connu un succès remarquable, avec des hits n°1 à son actif et un prestigieux BMI Award de la meilleure chanson de l'année pour le single de Thalia. Ses talents de compositrice ont été reconnus dans le monde entier et elle a travaillé
More news about: Mission Records LLC
Aug 07, 2025, 10:27 ET Gerina se une al legendario Chico & The Gypsies para crear una nueva y electrizante versión de "Arrepentido"
maestría musical. Como consumada compositora, Gerina ya ha logrado un éxito notable, con éxitos número uno en su haber y un prestigioso premio BMI a la mejor canción del año por el exitoso sencillo de Thalia. Sus habilidades como compositora han sido reconocidas a nivel mundial y ha trabajado con
More news about: Mission Records LLC
Aug 07, 2025, 09:07 ET Gerina Teams Up with Legendary Chico & The Gypsies for Electrifying New Version of "Arrepentido"
masterful musicianship. As an accomplished songwriter, Gerina has already achieved remarkable success, with #1 hits under her belt and a prestigious BMI Award for Best Song of the Year for Thalia's hit single. Her songwriting skills have been recognized globally, and she's worked with top artists in the
More news about: Mission Records LLC
Aug 07, 2025, 09:07 ET Gerina collabora con il leggendario gruppo Chico & The Gypsies per una nuova elettrizzante versione di "Arrepentido"
abilità musicale. In quanto affermata cantautrice, Gerina ha già ottenuto un successo notevole, con hit prime in classifica e un prestigioso premio BMI per la migliore canzone dell'anno per il singolo hit di Thalia. Le sue capacità di compositrice sono state riconosciute a livello mondiale e ha collaborato
More news about: Mission Records LLC
Aug 07, 2025, 06:25 ET Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity
demonstrate that orforglipron (6 mg, 12 mg, 36 mg) is superior to placebo in body weight reduction from baseline after 72 weeks in people with a BMI ≥30.0 kg/m² or a BMI ≥27.0 kg/m² with at least one weight-related comorbidity and a history of at least one self-reported unsuccessful dietary effort to lose body
More news about: Eli Lilly and Company
Aug 06, 2025, 08:31 ET MetaVia Extends 48 mg MAD Portion of Its Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity to 8 Weeks and Announces Fifth Weekly Dose in First Patient
therapeutic profile across primary, secondary and exploratory endpoints—including safety, tolerability, body weight, waist circumference, and body mass index (BMI), among others—and to further unlock its full therapeutic potential. Previously reported data from the 32 mg dose demonstrated strong weight loss effects
More news about: MetaVia Inc.